Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

ARDASIL is a vaccine indicated in girls and women 9-26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types 6, 11, 16, and 18: -- Cervical cancer -- Genital warts (condyloma acuminata) and the following precancerous or dysplastic lesions: -- Cervical adenocarcinoma in situ (AIS) -- Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3 -- Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3 -- Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3 -- Cervical intraepithelial neoplasia (CIN) grade 1 CONTRAINDICATIONS Hypersensitivity to the active substances or to any of the excipients of the vaccine. Individuals who develop symptoms indicative of hypersensitivity after receiving a dose of GARDASIL should not receive further doses of GARDASIL. PRECAUTIONS General As for any vaccine, vaccination with GARDASIL may not result in protection in all vaccine recipients. This vaccine is not intended to be used for treatment of active genital warts; cervical cancer; CIN, VIN, or VaIN. This vaccine will not protect against diseases that are not caused by HPV. GARDASIL has not been shown to protect against diseases due to non-vaccine HPV types. As with all injectable vaccines, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the vaccine. The decision to administer or delay vaccination because of a current or recent febrile illness depends largely on the severity of the symptoms and their etiology. Low-grade fever itself and mild upper respiratory infection are not generally contraindications to vaccination. Individuals with impaired immune responsiveness, whether due to the use of immunosuppressive therapy, a genetic defect, Human Immunodeficiency Virus (HIV) infection, or other causes, may have reduc
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:8/4/2015)... York , August 4, 2015 ... titled " Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, ... Others) - Global Industry Analysis, Size, Volume, Share, Growth, ... According to a new market report published by Transparency ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ...
(Date:8/4/2015)... Aug. 4, 2015 BioElectronics Corporation (OTC ... Musculoskeletal Pain Therapy medical devices, announced today that ... ActiPatch 7-day trial device has been published in ... Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 ... submitted an assessment.  Chronic pain ...
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 Research ... of the "Alcohol Ethoxylate Market by Application (Household ... Geographies Global Market Trends, Forecasts to 2019" report ... of alcohol ethoxylate was valued at $5,124.9 million in ... of about 3.5% from 2014 to 2019. The data ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3
... Regenerate Skeletal Muscle More,Efficiently than Male Cells, PITTSBURGH, April ... have a greater ability to regenerate skeletal,muscle tissue than ... Pittsburgh of UPMC. , The study, which is being ... Cell Biology, is the first ever to report a ...
... 10, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated announced data ... pipeline, including its Hsp90,inhibitor, epothilone and nuclear export ... American Association for Cancer Research,(AACR), being held in ... on Kosan's programs are as follows. The,location for ...
Cached Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3
(Date:8/5/2015)... ... August 05, 2015 , ... Jvion’s CEO, Shantanu Nigam ... Health IT & CIO Review. The designation is given to those leaders who are ... the success of Jvion and the firm’s clinical predictive analytic solutions. , A spokesperson ...
(Date:8/5/2015)... ... 05, 2015 , ... The June 6 opening of Chicago’s new elevated trail, the 606, has ... notice of a group of walkers at Sedgebrook senior living community in Lincolnshire. Known ... nearby forest preserves and twice per month to more distant places. When they read ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability Litigation, MDL ... of Illinois. The Motion to Dismiss was filed by the defendants, who include ...
(Date:8/5/2015)... ... ... Available in select spas and at http://www.lespausa.com , Phytomer ... oils. A perfect complement to Phytomer’s top selling product, ROSÉE VISAGE Cleansing Toning ... soothing properties. Formulated as a light and comfortable dry oil, it quickly penetrates the ...
(Date:8/5/2015)... ... , ... It is exciting times for people involved in ... PhUSE or CDISC are currently bringing in the harvest of their global collaboration ... European EMA. A move towards global harmonisation of electronic data submission standards helps ...
Breaking Medicine News(10 mins):Health News:Jvion’s Shantanu Nigam Named One of the 21 Health IT Leaders to Know 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3
... Looming Threats Require Healthcare Sustainability for America,s ... 3 The Healthcare Waste and Emergency ... raise awareness and provide education about two ... -- healthcare facility operational sustainability during a ...
... (NYSE: TYC ; BSX: TYC) will host its ... shareholders on March 12, 2009 at the Fairmont Hamilton Princess ... will begin at 9:00 a.m. Atlantic Time and will be ... Time. During the meetings, shareholders will vote on proposals ...
... 3 Nanophase Technologies (Nasdaq: ... and advanced nanoengineered products, announced today that the Company ... 28th, as its Chief Technology Officer, so that he ... was responsible for several of the Company,s key patents ...
... WXYZ is proud to announce that Peter,s Principles ... now be seen exclusively on Channel 7 in ... Peter Nielsen has hosted the nationally syndicated Peter,s Principles ... books and videos on health and fitness and is a frequent contributing ...
... the day has surprising impact on young people GAITHERSBURG, ... the importance of breakfast for students, Sodexo, a leading ... 470 school districts across the country, has created a ... time for National School Breakfast Week, March 2-6."Studies repeatedly ...
... to Improve, Automate Health Care in Master-Planned CommunitiesSCOTTSDALE, Ariz., ... of acres across the West but it,s his company,s ... would radically alter the use of energy grids. ... that message this week to The Wall Street Journal,s ...
Cached Medicine News:Health News:The Healthcare Waste and Emergency Preparedness Coalition Announces Its Official Formation 2Health News:Tyco to Host 2009 Annual General Meeting and Special General Meeting of Shareholders 2Health News:Nanophase Announces Changes in Principal Officers and Directors 2Health News:Nanophase Announces Changes in Principal Officers and Directors 3Health News:Peter Nielsen Has a New Home on WXYZ-TV! 2Health News:Sodexo Shares Top Breakfast Benefits for Students 2Health News:Innovative Plans by Major Arizona-Based Developer Sparks Landmark Energy Conservation Legislation in Multiple States to Urge Federal Action at Wall Street Journal Conference This Week with Gore, Google CEO & T. Boone Pickens 2
... Topical, Bactericide, Microbicide for professional degerming, ... in skin disinfectants combining quaternary and ... synergistic blend of emollients and surfactants. ... gram-positive organisms tested in 30 seconds. ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical solution is for ... Prep Spray is labeled for ... of cross contamination. The controlled ... method to the final step ...
... two and four ounce bottles ... the needs of procedural kit ... itself has been custom molded ... the cap perfectly. This product ...
Medicine Products: